Day One Biopharmaceuticals pany(DAWN) - 2024 Q2 - Quarterly Report
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 | --- | --- | |---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------| | | | | If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new ...